TIDMGSK

RNS Number : 8743S

GlaxoSmithKline PLC

13 July 2020

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr D Redfern 
===  ========================  =========================================== 
 b)   Position/status          Chief Strategy Officer 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 9 July 2020, on Ordinary 
                                 Shares held within an ISA. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.9271    25 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   N/A (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2020-07-10 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Ms V Whyte 
===  ========================  =========================================== 
 b)   Position/status          Company Secretary 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 9 July 2020, on Ordinary 
                                 Shares held within an ISA. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.9271    21 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   N/A (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2020-07-10 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHQXLFFBDLXBBK

(END) Dow Jones Newswires

July 13, 2020 12:42 ET (16:42 GMT)

Grafico Azioni Gsk (LSE:GSK)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Gsk
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Gsk